join
|
login
|
KOR
|
ENG
Introduction
Greetings
Organizational Structure
Vision and Strategy
Directions
Collaborative
Non-clinical Development
Service Overview
Advisory Expert Network
Service Procedures
Operational Policy
Q & A
Application and Inquiry
Online Application
My Page
My Application List
Notification Center
Announcements
Calendar
Related Websites
Job Openings
CND Campus
Learning Resources
Case Studies
WebTox
Toxicology Overview Videos
Video Archive
Open Discussion Board
Logout
My Page
Introduction
Greetings
Organizational Structure
Vision and Strategy
Directions
Collaborative Non-clinical Development
Service Overview
Advisory Expert Network
Service Procedures
Operational Policy
Q&A
Application and Inquiry
Online Application
My Page
My Application List
Notification Center
Announcements
Calendar
Related Websites
Job Openings
CND Campus
Learning Resources
Case Studies
WebTox
커뮤니티
회원
회원가입
로그인
아이디/비번찾기
이용약관
개인정보취급방침
Learning Resources
Case Studies
WebTox
T-cell immunotherapies and the role of nonclinical assessment-the balance between efficacy and pathology
Comment
0
|
Views
21952
|
By
관리자
|
Date
2019-01-07
안녕하십니까, CND 관리자입니다.
이번 공부거리는 T cell immunotherapy의 비임상적 평가 현황을 다룬 리뷰논문입니다.
T cell immunotherapy는 비종양활성, 사이토카인 방출 증후군, 신경독성 등 다양한 이슈와 연관되어 있습니다.
많은 참고 부탁드립니다.
감사합니다.
첨부파일
T-cell immunotherapies and the role of nonclinical assessment-the balance between efficacy and pathology.pdf
downloads : 55
에
새로운 글이 작성되었습니다.
Logout
My Page
Logout
My Page
